Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-24-22 | Jun-25-22 | Mar-26-22 | Dec-25-21 | Sep-25-21 | Jun-26-21 | Mar-27-21 | Dec-26-20 |
| | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Revenues |
| Breast Health | 1,227.6 | 1,286.8 | 1,353.0 | 1,378.9 | 1,352.3 | 1,307.1 | 1,182.1 | 1,153.6 |
| Diagnostics | 3,018.5 | 3,334.4 | 3,439.8 | 3,517.2 | 3,695.0 | 3,797.1 | 3,663.8 | 2,918.5 |
| GYN Surgical | 523.0 | 511.6 | 501.4 | 498.3 | 488.0 | 466.3 | 389.9 | 381.1 |
| Skeletal Health | 93.6 | 93.3 | 97.5 | 99.2 | 97.0 | 92.1 | 81.4 | 82.5 |
| |
| EBITDA |
| Breast Health | 241.9 | 270.6 | 316.4 | 334.7 | 336.9 | 321.6 | 228.9 | 237.2 |
| Diagnostics | 1,633.4 | 1,928.8 | 2,010.1 | 2,161.0 | 2,400.6 | 2,573.1 | 2,542.3 | 1,899.2 |
| GYN Surgical | 201.6 | 186.6 | 143.2 | 164.6 | 152.0 | 162.0 | 118.2 | 111.5 |
| Skeletal Health | -6.4 | -5.7 | -3.2 | -2.0 | -2.2 | 3.2 | -3.6 | -1.6 |
| |
| EBIT |
| Breast Health | 183.1 | 212.1 | 261.1 | 279.6 | 284.2 | 269.3 | 177.2 | 185.3 |
| Diagnostics | 1,359.4 | 1,642.4 | 1,727.5 | 1,887.5 | 2,140.2 | 2,334.2 | 2,308.0 | 1,664.7 |
| GYN Surgical | 104.9 | 90.8 | 48.9 | 71.8 | 58.9 | 70.5 | 28.9 | 24.2 |
| Skeletal Health | -7.2 | -6.5 | -4.0 | -2.7 | -2.9 | 2.5 | -4.2 | -2.3 |
| |
| Mix |
| Breast Health | 25.2% | 24.6% | 25.1% | 25.1% | 24.0% | 23.1% | 22.2% | 25.4% |
| Diagnostics | 62.1% | 63.8% | 63.8% | 64.0% | 65.6% | 67.1% | 68.9% | 64.3% |
| GYN Surgical | 10.8% | 9.8% | 9.3% | 9.1% | 8.7% | 8.2% | 7.3% | 8.4% |
| Skeletal Health | 1.9% | 1.8% | 1.8% | 1.8% | 1.7% | 1.6% | 1.5% | 1.8% |
| |
| Growth |
| Breast Health | -9.2% | -1.6% | 14.5% | 19.5% | 17.4% | 8.4% | -9.5% | -12.6% |
| Diagnostics | -18.3% | -12.2% | -6.1% | 20.5% | 75.8% | 158.3% | 194.8% | 139.1% |
| GYN Surgical | 7.2% | 9.7% | 28.6% | 30.8% | 29.7% | 19.4% | -13.6% | -14.9% |
| Skeletal Health | -3.5% | 1.3% | 19.8% | 20.2% | 19.6% | 5.4% | -15.7% | -15.0% |
|